Torrent Pharmaceuticals
TORNTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Samir Mehta Listing date: Oct. 24, 1994 · Employees: 13505 · Ahmedabad · http://www.torrentpharma.com

Stock Price vs Company Growth
1d
0.1%
1w
2.0%
1m
6.2%
3m
6.1%
6m
20.6%
1y
14.0%
5y
24.9%
10y
19.3%
all
27.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 3,797 0.1%
3,480
3,881
Company Overview

Sales
12,248 Cr
Growth: 8.6%
Profit after Tax
2,140 Cr
Growth: 6.9%
Large Cap
1,28,523 Cr
P/E: 59.9x
Industry P/E: 33.3x
Fundamentals

Sales (Cr) ₹ 12,248
Growth 8.6%
EBITDA 32.6%
P/S 10.5x
Dividend 1.0%
P/E 59.9x
Book Value ₹ 258
PEG Ratio 7.0x
ROE 26.2%
P/B 14.7x
Shareholding Pattern

Institutions
Mirae Asset Focused Fund
2.16 %
Qualified Institutional Buyer
1.63 %
Uti-Unit Linked Insurance Plan
1.28 %
Promoters
Torrent Investments Private Limited
71.25 %
Others
Ifpf
0.1 %
Increase    Decrease    No change
Company Profile Detailed

The Company is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations. Torrent Pharma is a leading player in the areas of Cardiovascular and Central Nervous Systems, having achieved significant presence in segments of Nephrology, Oncology, Pulmonology, Gynecology and Pediatric treatments. Business segmentsThe company operates in two key business segments - Branded Generics (BGx) and Generics (Gx).
Investors (88)
Followers (13)